BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6698547)

  • 1. Apolipoprotein E phenotypes and hyperlipidemia.
    Utermann G; Kindermann I; Kaffarnik H; Steinmetz A
    Hum Genet; 1984; 65(3):232-6. PubMed ID: 6698547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E polymorphism and hyperlipidemia.
    Assmann G; Schmitz G; Menzel HJ; Schulte H
    Clin Chem; 1984 May; 30(5):641-3. PubMed ID: 6713624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations.
    Ehnholm C; Lukka M; Kuusi T; Nikkilä E; Utermann G
    J Lipid Res; 1986 Mar; 27(3):227-35. PubMed ID: 3734624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia.
    Parhofer KG; Richter WO; Schwandt P
    Horm Metab Res; 1990 Nov; 22(11):589-94. PubMed ID: 2272605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E phenotypes in hyperlipidaemic patients and their implications for treatment.
    Janus ED; Grant S; Lintott CJ; Wardell MR
    Atherosclerosis; 1985 Nov; 57(2-3):249-66. PubMed ID: 3866582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E phenotypes and hyperlipidemia in patients under maintenance hemodialysis.
    Feussner G; Wey S; Bommer J; Deppermann D; Grützmacher P; Ziegler R
    Hum Genet; 1992 Jan; 88(3):307-12. PubMed ID: 1733833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E polymorphism in health and disease.
    Utermann G
    Am Heart J; 1987 Feb; 113(2 Pt 2):433-40. PubMed ID: 3544759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E phenotypes in patients with myocardial infarction.
    Utermann G; Hardewig A; Zimmer F
    Hum Genet; 1984; 65(3):237-41. PubMed ID: 6698548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of type III hyperlipoproteinemia.
    Feussner G; Piesch S; Dobmeyer J; Fischer C
    Genet Epidemiol; 1997; 14(3):283-97. PubMed ID: 9181357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III.
    Utermann G; Vogelberg KH; Steinmetz A; Schoenborn W; Pruin N; Jaeschke M; Hees M; Canzler H
    Clin Genet; 1979 Jan; 15(1):37-62. PubMed ID: 215360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and role of apo E phenotype in familial hypercholesterolemia and non-familial hyperlipidemia in the Japanese.
    Kitahara M; Shinomiya M; Shirai K; Saito Y; Yoshida S
    Atherosclerosis; 1990 Jun; 82(3):197-204. PubMed ID: 2375785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal in vivo metabolism of apolipoprotein E4 in humans.
    Gregg RE; Zech LA; Schaefer EJ; Stark D; Wilson D; Brewer HB
    J Clin Invest; 1986 Sep; 78(3):815-21. PubMed ID: 3745440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlipoproteinemia type V and apolipoprotein E4.
    Stuyt PM; Stalenhoef AF; Demacker PN; van't Laar A
    Lancet; 1982 Oct; 2(8304):934. PubMed ID: 6126778
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia.
    Ghiselli G; Schaefer EJ; Zech LA; Gregg RE; Brewer HB
    J Clin Invest; 1982 Aug; 70(2):474-7. PubMed ID: 7096573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan.
    Kobori S; Nakamura N; Uzawa H; Shichiri M
    Atherosclerosis; 1988 Jan; 69(1):81-8. PubMed ID: 3355609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of apoprotein epsilon 2 homozygosity on nephrotic hyperlipidemia.
    Joven J; Vilella E
    Clin Nephrol; 1997 Sep; 48(3):141-5. PubMed ID: 9342484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.
    Rall SC; Weisgraber KH; Innerarity TL; Mahley RW
    Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4696-700. PubMed ID: 6289314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new isoform of apolipoprotein E--apo E-5--associated with hyperlipidemia and atherosclerosis.
    Yamamura T; Yamamoto A; Hiramori K; Nambu S
    Atherosclerosis; 1984 Feb; 50(2):159-72. PubMed ID: 6712769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype study of apolipoprotein E isoforms in hyperlipoproteinaemic patients.
    Ghiselli G; Gregg RE; Zech LA; Schaefer EJ; Brewer HB
    Lancet; 1982 Aug; 2(8295):405-7. PubMed ID: 6124804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E gene polymorphism alters lipids before pancreas transplantation.
    Balakrishnan S; Colling C; Burkman T; Erickson J; Lyden E; Maheshwari H; Mack-Shipman L; Lane J; Larsen J
    Transplantation; 2002 Oct; 74(7):974-7. PubMed ID: 12394840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.